Bioline Rx reported $2.21M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Arca Biopharma ABIO:US USD 1.74M 513K
Bio Path BPTH:US USD 1.19M 34K
Bluebird Bio BLUE:US USD 33.4M 3.29M
Capricor Therapeutics CAPR:US USD 2.56M 208.29K
Idera Pharmaceuticals IDRA:US USD 2.27M 391K
Ophthotech OPHT:US USD 17.54M 1.44M